In the study of Sun et al. [23], miR-9 mediates the down-regulation of BRCA1 gene, which in turn hinders the repair of DNA damage in OC, suggesting that the therapeutic effect of OC can be improved by increasing the sensitivity of cancer cells to DNA damage. Here, BRCA1 is linked to cancer.